Loading…

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Featured Topics: Clinical Operations [clear filter]
←View All Dates
Wednesday, June 21
 

10:30am

#309: Big Data: Combining Registries and Legacy Clinical Trial Databases S505ab #310: New Site Paradigm: Just in Time Sites N229 #311: Next Generation Patient Recruitment: Part 2 of 2 S501abc #316: Quantitative Metrics to Capture the Value of Patient Engagement N426a #317: Evolution of Novel Registration Endpoints as Diseases Become Chronic S404bc #321: Engagement, Education, Networks, Media, and Societies in Rare Diseases: The MUST Haves S503ab #326: Optimizing Early Clinical Strategies to Support Breakthrough Therapy Designation S401a

2:00pm

#357: Biosimilars and Generics: Access Versus Innovation S405b #338: Risk-Based Monitoring: Convergence of Technology, Processes, and People N226 #344: Minding the Gaps: Using Totality of Evidence in the Clinical and CMC Contexts to Support Regulatory Approval S404a #350: Innovative Designs and Statistical Approaches for Small Trials: Rare Disease or Pediatric Indications S502ab #353: What Do the Experts Believe? Translating Expert Knowledge and Judgment Into a Quantitative Belief Distribution S401bc #354: Experimental Studies: New Approaches to Study Designs to Facilitate Early Phase Decision Making S405a #356: Value-Based Conversations with Payers: Issues, Opportunities, and Barriers S503ab

4:00pm

#364: Risk-Based Monitoring: Convergence of Technology, Processes, and People: Panel Discussion N226 #365: Next Generation Predictive Analytics S503ab #366: Are We Ready for Telemedicine-Powered Clinical Trials? S504abc #369: How Is Digital Patient Engagement Impacting Trial Participation? S404a #374: Global Perspective on ICH: Part 2 of 2 N228 #377: Increasing Participation in Clinical Trials Among Under-Represented Populations S505ab #380: Effective Portfolio Management and How to Ensure You Get the Value Out of the Decisions Made N426a #381: Maximizing Success in Partner Collaborations N426b #383: Safety Issues in First-in-Human Studies S405b #384: The Increasing Role for Big Data for Late Phase Drug and Postapproval Purposes S401a